Fluconazolum
Fluconazolum Aflofarm belongs to a group of antifungal medicines. The active substance of the medicine is flukonazol.
Fluconazolum Aflofarm is used to treat infections caused by pathogenic fungi and can also be used to prevent yeast infections. The most common cause of fungal infections is yeast of the genus Candida.
The doctor may recommend taking this medicine for the following fungal infections:
The doctor may recommend taking this medicine to treat the following fungal infections:
Before starting to take Fluconazolum Aflofarm, the patient should discuss it with their doctor or pharmacist if:
Patient taking Fluconazolum Aflofarm have experienced severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS). If the patient experiences any of the severe skin reactions described in section 4, they should stop taking Fluconazolum Aflofarm and seek medical help immediately.
The patient should tell their doctor or pharmacist about all medicines they are taking, have recently taken, or plan to take.
The patient should immediatelytell their doctor if they are taking:
because they should not be taken with Fluconazolum Aflofarm (see "When not to take Fluconazolum Aflofarm").
The patient should inform their doctor if they are taking any of the following medicines:
The medicine can be taken with or without food.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
If the patient plans to become pregnant, it is recommended that they wait for a week after taking a single dose of fluconazole before becoming pregnant.
In case of longer treatment cycles with fluconazole, the patient should discuss the need for proper contraception during treatment and for a week after the last dose with their doctor.
If the patient is pregnant, thinks they may be pregnant, or is trying to become pregnant, they should not take fluconazole unless their doctor recommends it.
If the patient becomes pregnant or thinks they may be pregnant while taking this medicine or within a week of taking the last dose, they should contact their doctor.
There have been reports of children with birth defects of the skull, ears, and femur and humerus bones, born to mothers treated for coccidioidomycosis with high doses of fluconazole (400-800 mg per day) for at least 3 months. The relationship between fluconazole use and these cases is unclear.
The medicine may affect the ability to drive and use machines. If dizziness or seizures occur, the patient should not drive or operate machinery.
If the patient has been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per capsule, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as prescribed by the doctor. If the patient has any doubts, they should consult their doctor or pharmacist.
The capsule should be swallowed whole, with a glass of water. Capsules are best taken at the same time every day. For children who cannot swallow the capsule and for young children, for whom precise dosing based on body weight is necessary, fluconazole is available in a syrup form.
The recommended dosing, depending on the type of infection, is presented below.
Indication | Dosage |
Treatment of cryptococcal meningitis | 400 mg on the first day, then 200 mg to 400 mg once a day for 6 to 8 weeks or longer if necessary. The dose may be increased to 800 mg. |
Prevention of relapses of cryptococcal meningitis | 200 mg once a day until the doctor recommends stopping treatment. |
Treatment of coccidioidomycosis | 200 mg to 400 mg once a day for 11 months to 24 months or longer if necessary. The dose may be increased to 800 mg. |
Treatment of infections of internal organs caused by Candida yeast | 800 mg on the first day, then 400 mg once a day until the doctor recommends stopping treatment. |
Treatment of yeast infections of the mucous membranes of the mouth, throat, and mouth sores associated with the use of dental prostheses | 200 mg to 400 mg on the first day, then 100 mg to 200 mg until the doctor recommends stopping treatment. |
Yeast infections (thrush) of the mucous membranes - the dose depends on the location | 50 mg to 400 mg once a day for 7 to 30 days, until the doctor recommends stopping treatment. |
Prevention of yeast infections of the mouth and throat | 100 mg to 200 mg once a day, or 200 mg 3 times a week, if the patient is at increased risk of relapse. |
Treatment of yeast infections of the genital organs | A single dose of 150 mg. |
Prevention of relapses of vaginal yeast infections | 150 mg every third day, for a total of 3 doses (days 1, 4, and 7), and then once a week for 6 months (if the patient is at increased risk of relapse). |
Treatment of fungal skin and nail infections | Depending on the location of the infection, 50 mg once a day, 150 mg once a week, 300 to 400 mg once a week for 1 to 4 weeks (in athlete's foot, treatment may be necessary for up to 6 weeks, in nail infections, treatment should be continued until the infected nail is replaced by a new, healthy one). |
Prevention of yeast infections (if the patient's immune system is weak and not functioning properly) | 200 to 400 mg once a day, if the patient is at increased risk of relapse. |
The dose prescribed by the doctor should be taken (as for adult patients or as for children).
The maximum dose for children is 400 mg per day.
The dose will be determined based on the child's body weight in kilograms.
Indication | Daily dose |
Yeast infections of the mucous membranes of the mouth and throat - the dose and duration of treatment depend on the severity and location of the infection | 3 mg per kg of body weight (on the first day, a dose of 6 mg per kg of body weight can be given). |
Cryptococcal meningitis or yeast infections of internal organs | 6 to 12 mg per kg of body weight. |
Prevention of yeast infections in children (if the immune system is not functioning properly) | 3 to 12 mg per kg of body weight. |
Children from 3 to 4 weeks of age
The same dose as above, but given every other day. The maximum dose is 12 mg per kg of body weight every 48 hours.
Children under 2 weeks of age
The same dose as above, given every 3 days. The maximum dose is 12 mg per kg of body weight every 72 hours.
The usual dose for adults is given, unless the patient has kidney function disorders.
The doctor may recommend changing the dose, depending on kidney function.
Taking too many capsules at once can cause discomfort. The patient should immediately contact the emergency department of the nearest hospital. Symptoms of possible overdose may include hearing, vision, or sensation disorders, thinking about untrue things (hallucinations and paranoid behavior). Symptomatic treatment (life-supporting treatment and stomach lavage, if necessary) may be indicated.
The patient should not take a double dose to make up for a missed dose. If a dose is missed, it should be taken as soon as remembered. If it is almost time for the next dose, the missed dose should not be taken.
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, Fluconazolum Aflofarm can cause side effects, although not everybody gets them.
Some patients may experience allergic reactions, but severe allergic reactions are rare.
If the patient experiences any side effects, they should consult their doctor or pharmacist.
This includes any side effects not listed in this leaflet.
Fluconazolum Aflofarm may affect the liver. Symptoms of liver disorders include:
Frequent(in 1 to 10 out of 100 patients):
Uncommon(in 1 to 10 out of 1,000 patients):
Rare(in 1 to 10 out of 10,000 patients):
Frequency not known(frequency cannot be estimated from available data):
If the patient experiences any side effects, including any not listed in this leaflet, they should tell their doctor or pharmacist.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocides of the Office for Registration of Medicinal Products, Medical Devices, and Biocides
Al. Jerozolimskie 181 C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
There are no special recommendations for storing the medicine.
The medicine should not be taken after the expiry date stated on the packaging and blister. The expiry date refers to the last day of the month.
Lot - batch number
EXP - expiry date
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Fluconazolum Aflofarm, 200 mg: a hard gelatin capsule, size ‘0’, 21.40 ± 0.40 mm long, with a white to almost white body and cap, marked with yellow ink: "200" on the body and "FL" on the cap.
The packaging is a PVC/PVDC-Aluminum blister pack, placed in a cardboard box with a leaflet.
The packaging contains: 7 capsules.
Aflofarm Farmacja Polska Sp. z o.o.
ul. Partyzancka 133/151
95-200 Pabianice
phone: (42) 22-53-100
APL Swift Services (Malta) Ltd,
HF26, Hal Far Industrial Estate,
Hal Far, Birzebbugia, BBG 3000,
Malta
Generis Farmacȇutica, S.A.
Rua João de Deus, n.o 19, Venda Nova,
2700-487 Amadora,
Portugal
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.